EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,008,607 | +14.2% | 137,787 | -0.0% | 0.00% | 0.0% |
Q2 2023 | $2,634,592 | -1.7% | 137,829 | -0.1% | 0.00% | 0.0% |
Q1 2023 | $2,681,047 | -21.0% | 137,987 | -34.7% | 0.00% | 0.0% |
Q4 2022 | $3,391,867 | -74.2% | 211,443 | -87.4% | 0.00% | -80.0% |
Q3 2022 | $13,163,150 | -41.4% | 1,677,306 | +55.5% | 0.01% | -33.3% |
Q2 2022 | $22,464,000 | -38.1% | 1,078,918 | -32.6% | 0.02% | -16.7% |
Q1 2022 | $36,287,000 | -0.8% | 1,600,629 | -20.0% | 0.02% | +20.0% |
Q4 2021 | $36,571,000 | -5.8% | 2,000,602 | +8.9% | 0.02% | -11.8% |
Q3 2021 | $38,838,000 | +121.4% | 1,837,186 | +110.2% | 0.02% | +112.5% |
Q4 2020 | $17,542,000 | -83.7% | 874,031 | -80.2% | 0.01% | -85.7% |
Q3 2020 | $107,826,000 | -14.4% | 4,410,094 | -16.9% | 0.06% | -21.1% |
Q2 2020 | $125,920,000 | +102.3% | 5,304,083 | +46.8% | 0.07% | +65.1% |
Q1 2020 | $62,234,000 | +9161.0% | 3,614,091 | +9376.8% | 0.04% | – |
Q4 2019 | $672,000 | -23.8% | 38,136 | -23.5% | 0.00% | – |
Q3 2019 | $882,000 | -74.2% | 49,854 | -68.8% | 0.00% | -100.0% |
Q2 2019 | $3,418,000 | +340.5% | 159,966 | +390.8% | 0.00% | – |
Q1 2019 | $776,000 | -42.0% | 32,594 | -46.0% | 0.00% | -100.0% |
Q1 2018 | $1,338,000 | -50.9% | 60,400 | -32.6% | 0.00% | -50.0% |
Q4 2017 | $2,724,000 | -90.0% | 89,600 | -92.1% | 0.00% | -88.9% |
Q3 2017 | $27,314,000 | -4.8% | 1,127,292 | -3.2% | 0.02% | -5.3% |
Q2 2017 | $28,689,000 | – | 1,164,798 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |